BRAF and colorectal carcinoma: Nevertheless, a recent meta-analysis by Manthravadi S et al., with 1164 MSI non-metastatic CRC, showed that the presence of BRAF mutation entails worse survival, without statistically significant differences in disease recurrence [48,49,50].